Emperipolesis Mediated by CD8 T Cells Is a Characteristic Histopathologic Feature of Autoimmune Hepatitis

Clinical Reviews in Allergy and Immunology

Volumn 48, Issue 2-3, 2015, Pages 226-235

  Miao, Qi ^a   Bian, Zhaolian ^a   Tang, Ruqi ^a   Zhang, Haiyan ^a   Wang, Qixia ^a   Huang, Shanshan ^a   Xiao, Xiao ^a   Shen, Li ^a   Qiu, Dekai ^a   Krawitt, Edward L ^b   Gershwin, M Eric ^c   Ma, Xiong ^a  

^a School of Medicine   (China)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmune hepatitis; Autoimmune liver disease; Chronic hepatitis; Emperipolesis; Hepatocyte injury; Inflammation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; CHRONIC HEPATITIS; CONFOCAL MICROSCOPY; EMPERIPOLESIS; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; AGED; BIOPSY; DRUG-INDUCED LIVER INJURY; HEPATITIS B, CHRONIC; HEPATITIS, AUTOIMMUNE; IMMUNOLOGY; LIVER CELL; LIVER CIRRHOSIS, BILIARY; METABOLISM; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; APOPTOSIS; BIOPSY; CD8-POSITIVE T-LYMPHOCYTES; DRUG-INDUCED LIVER INJURY; EMPERIPOLESIS; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS, AUTOIMMUNE; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; ROC CURVE; T-LYMPHOCYTE SUBSETS;

EID: 84928123243     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-014-8432-0     Document Type: Article

References (36)

1. Gershwin M, Krawitt E (2014) Autoimmune hepatitis: 50 years of (slow) progress. Hepatology 59:754–756
2. Manns MP, Czaja AJ, Gorham JD et al (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51(6):2193–2213
3. Lohse AW, Mieli-Vergani G (2011) Autoimmune hepatitis. J Hepatol 55(1):171–182
4. Qiu D, Wang Q, Wang H et al (2011) Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 54(2):340–347
5. Longhi MS, Ma Y, Mieli-Vergani G, Vergani D (2010) Aetiopathogenesis of autoimmune hepatitis. J Autoimmun 34(1):7–14
6. Ohira H, Takahashi A (2012) Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan. Hepatol Res 42(2):131–138
7. Dienes HP (1989) Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity. Veroff Pathol 132:1–107
8. Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31(5):929–938
9. Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48(1):169–176
10. Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696–699
11. Kleiner DE, Chalasani NP, Lee WM et al (2014) Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. Hepatology 59(2):661–670
12. Suzuki A, Brunt EM, Kleiner DE et al (2011) The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 54(3):931–939
13. Humble JG, Jayne WH, Pulvertaft RJ (1956) Biological interaction between lymphocytes and other cells. Br J Haematol 2(3):283–294
14. Overholtzer M, Brugge JS (2008) The cell biology of cell-in-cell structures. Nat Rev Mol Cell Biol 9(10):796–809
15. Larsen TE (1970) Emperipolesis of granular leukocytes within megakaryocytes in human hemopoietic bone marrow. Am J Clin Pathol 53(4):485–489
16. Saxena S, Beena KR, Bansal A, Bhatnagar A (2002) Emperipolesis in a common breast malignancy. A case report. Acta Cytol 46(5):883–886
17. Sinkovics JG, Shullenberger CC, Howe CD (1966) Cell destruction by lymphocytes. Lancet 287:1215–1216
18. Sandilands GP, Reid FM, Gray KG, Anderson JR (1978) Lymphocyte emperipolesis revisited: I. Development of in vitro assay and preliminary characterisation of the lymphocyte subpopulation involved. Immunology 35(2):381–389
19. Chen YH, Wang S, He MF et al (2013) Prevalence of heterotypic tumor/immune cell-in-cell structure in vitro and in vivo leading to formation of aneuploidy. PLoS One 8(3):e59418
20. Takeuchi M, Inoue T, Otani T, Yamasaki F, Nakamura S, Kibata M (2010) Cell-in-cell structures formed between human cancer cell lines and the cytotoxic regulatory T-cell line HOZOT. J Mol Cell Biol 2(3):139–151
21. Tamura A, Kikuchi S, Hata M et al (2005) Achlorhydria by ezrin knockdown: defects in the formation/expansion of apical canaliculi in gastric parietal cells. J Cell Biol 169(1):21–28
22. Tanaka M, Aze Y, Fujita T (1997) Adhesion molecule LFA-1/ICAM-1 influences on LPS-induced megakaryocytic emperipolesis in the rat bone marrow. Vet Pathol 34(5):463–466
23. Okuyama S, Mishina H, Yamamoto K, Matsuzawa T (1979) Emperipolesis as a cancer antagonism: report of 2 cases. Sci Rep Res Inst Tohoku Univ Med 26(1–2):11–17
24. Wang X, Li W (1987) Mechanisms of natural killer cell-mediated tumor cell cytolysis at a single cell level. J Med Coll PLA 2:107–117
25. Wang S, Guo Z, Xia P et al (2009) Internalization of NK cells into tumor cells requires ezrin and leads to programmed cell-in-cell death. Cell Res 19(12):1350–1362
26. Colmenero I, Molho-Pessach V, Torrelo A, Zlotogorski A, Requena L (2012) Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai–Dorfman disease. Am J Dermatopathol 34(3):315–320
27. Djaldetti M, Strauss Z (1982) Emperipolesis by megakaryocytes in patients with non-Hodgkin's lymphoma and megaloblastic anemia. J Submicrosc Cytol 14(2):407–413
28. Kumari N, Kathuria R, Srivastav A, Krishnani N, Poddar U, Yachha SK (2013) Significance of histopathological features in differentiating autoimmune liver disease from nonautoimmune chronic liver disease in children. Eur J Gastroenterol Hepatol 25(3):333–337
29. Mallick S, Ghosh R, Iyer VK, Jain D, Mathur SR (2013) Cytomorphological and morphometric analysis of 22 cases of Rosai–Dorfman disease: a large series from a tertiary care centre. Acta Cytol 57(6):625–632
30. Chabot S, Fakhfakh A, Beland K et al (2013) Mouse liver-specific CD8(+) T-cells encounter their cognate antigen and acquire capacity to destroy target hepatocytes. J Autoimmun 42:19–28
31. Longhi MS, Hussain MJ, Bogdanos DP et al (2007) Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 46(2):472–484
32. Wen L, Peakman M, Lobo-Yeo A et al (1990) T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. Lancet 336(8730):1527–1530
33. Krawitt EL, Kilby AE, Albertini RJ et al (1988) An immunogenetic study of suppressor cell activity in autoimmune chronic active hepatitis. Clin Immunol Immunopathol 46(2):249–257
34. Ehser J, Holdener M, Christen S et al (2013) Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis. J Autoimmun 42:39–49
35. Hintermann E, Holdener M, Bayer M et al (2011) Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model. J Autoimmun 37(3):242–253
36. Benseler V, Warren A, Vo M et al (2011) Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci U S A 108(40):16735–16740